Moreover, CT-1 levels might be related to insulin resistance in subjects with metabolic syndrome [43]; thus, we speculated that the timing of progression of steatosis to metabolic syndrome or type 2 diabetes mellitus with insulin resistance status was relevant to the CT-1 levels. This evidence concerns the gene CTF1 and Insulin resistance.